Filtern
Volltext vorhanden
- ja (221)
Gehört zur Bibliographie
- ja (221)
Erscheinungsjahr
Dokumenttyp
- Artikel / Aufsatz in einer Zeitschrift (221) (entfernen)
Sprache
- Englisch (221) (entfernen)
Schlagworte
- Virologie (33)
- T cells (14)
- Immunologie (13)
- HIV (12)
- SARS-CoV-2 (11)
- measles virus (10)
- regulatory T cells (7)
- dendritic cells (6)
- immune evasion (5)
- COVID-19 (4)
- autoimmunity (4)
- cell staining (4)
- ceramides (4)
- monocytes (4)
- sphingolipids (4)
- sphingomyelinase (4)
- Dendritische Zelle (3)
- Lymphozyt (3)
- Medizin (3)
- Parkinson’s disease (3)
- T cell receptor (3)
- antiretroviral therapy (3)
- ceramide (3)
- evolution (3)
- flow cytometry (3)
- gene expression (3)
- herpesvirus (3)
- immunology (3)
- macrophages (3)
- phosphoantigen (3)
- BTN3 (2)
- CD28 (2)
- CD4(+) (2)
- Candida albicans (2)
- Dendritic cells (2)
- GFAP (2)
- GM-CSF (2)
- Human papillomavirus (2)
- ME/CFS (2)
- Masernvirus (2)
- Parkinson (2)
- RNA polymerase II (2)
- South Africa (2)
- T cell receptors (2)
- TGF-BETA (2)
- TNF-alpha (2)
- acid ceramidase inhibitor ceranib-2 (2)
- acid sphingomyelinase (2)
- alpaca (2)
- antibodies (2)
- antigen presentation (2)
- binding protein (2)
- bone marrow (2)
- butyrophilin (2)
- butyrophilin 3 (2)
- cytokine secretion (2)
- cytotoxic T cells (2)
- dendritic cell (2)
- depression (2)
- domain (2)
- foamy virus (2)
- foamy viruses (2)
- gene regulation (2)
- herpes simplex virus (2)
- human (2)
- identification (2)
- in-vivo (2)
- infection (2)
- inflammation (2)
- lymph nodes (2)
- measels virus (2)
- measles (2)
- mouse (2)
- neuroprotection (2)
- neutral sphingomyelinase-2 (2)
- peripheral nervous system (2)
- plasma membrane (2)
- reverse transcriptase (2)
- small interfering RNAs (2)
- sphingosine kinase inhibitor SKI-II (2)
- sphingosine-1-phosphate (2)
- transcription (2)
- translation (2)
- viral infection (2)
- viral load (2)
- virology (2)
- γδ T cell (2)
- 1,2-benzisothiazolinone (1)
- 2',7'-dichlorofluorescin (1)
- 3D tissue model (1)
- 60-nucleotide duplication (1)
- ABCG2 (1)
- ACH-2 (1)
- AIDS (1)
- AKT-signaling (1)
- ATP-adenosine triphosphate (1)
- Activation (1)
- Adaptive cell transfer (1)
- Allotransplantation (1)
- Alpha therapy (1)
- Alzheimer’s disease (1)
- Antisense (1)
- Apoptosis (1)
- Aspergillus fumigatus (1)
- Auto-antibodies (1)
- Autoimmune diseases (1)
- B cells (1)
- B-cell (1)
- BBC3 (1)
- BCG (1)
- BK virus (1)
- BTN (1)
- BTN2 (1)
- BTN2A1 (1)
- BTN3A1 (1)
- Biologie (1)
- Biomarkers (1)
- Bone marrow transplantantation (1)
- Bowen’s disease, periungual (1)
- Braak (1)
- Brugia Malayi (1)
- Bruton Tyrosine Kinase (1)
- Bryophyta (1)
- C-terminal domain (1)
- CCS (1)
- CD28 costimulation (1)
- CD28 superagonists (1)
- CD39 (1)
- CD4(+) T-cells (1)
- CD4(+)CD25(+) (1)
- CD4+ T cells (1)
- CD46 (1)
- CD4\(^{+}\) T cells (1)
- CD4\(^{+}\) T helper cells (1)
- CD73 (1)
- CD8+ T cells (1)
- CNS infection (1)
- COVID‐19 (1)
- COVID‐19 vaccination (1)
- CRAC (1)
- CSF (1)
- Ca2+ (1)
- Calu-3 (1)
- Cancer (1)
- Candida (1)
- Cell signalling (1)
- Ceramide (1)
- ChIP-seq (1)
- Children (1)
- D665 (1)
- DAPI staining (1)
- DAT (1)
- DETC (1)
- DNA sequence (1)
- DNA transcription (1)
- DNA traps (1)
- Disease genetics (1)
- Disease severity (1)
- Donor lymphocytes (1)
- EBV (1)
- EVER1 (1)
- EVER2 (1)
- Einfluss (1)
- Enterovirus (1)
- Epidemiology (1)
- Escherichia coli infections (1)
- Evaluation (1)
- Expression (1)
- Extracellular domain (1)
- Factor receptor (1)
- Fanconi Anemia (1)
- Flt3L (1)
- Foamy virus (1)
- GBS (1)
- GRP78 (1)
- GagPol fusion protein (1)
- Gen (1)
- German people (1)
- Germany (1)
- Golgi (1)
- Graft versus Tumor (1)
- Graft-versus-leukemia (1)
- HAND (1)
- HHV-6 (1)
- HIV diagnosis and management (1)
- HIV infections (1)
- HIV neurocognitive impairment (1)
- HIV-1 subtype AG (1)
- HIV-1-infected patients (1)
- HIV-1; subtype C; proviral plasmid; viral replication; resistance assays; Vpu; CD317; CD4 (1)
- HIV-Infektion (1)
- HTLV-I (1)
- Hamburg (1)
- Herpes (1)
- Hsp90 (1)
- Human foamy virus bel-l transactivator; Expression in insect cells (1)
- Hypnales (1)
- ICP27 (1)
- ICP4 (1)
- IL-2 (1)
- IL-3 (1)
- IL1RA (1)
- IL‐10 (1)
- Ibrutinib (1)
- IgG (1)
- Immunology (1)
- Immunosuppression (1)
- Immunstimulation (1)
- IncRNA (1)
- Infectious disease (1)
- Integrase (1)
- JCV (1)
- Jurkat cells (1)
- KDELR2 (1)
- KRAS (1)
- Kerinokeratosis papulosa (1)
- Kongress (1)
- Krebs <Medizin> (1)
- LAD (1)
- LFA-1 (1)
- LIF (1)
- Langerhans cells (1)
- Ligand (1)
- MEK/ERK-signaling (1)
- MHC I (1)
- MHC II (1)
- MIR-155 (1)
- MPO (1)
- MRI (1)
- MS (1)
- MV receptor (1)
- MV transcription (1)
- Major splice donor (1)
- Malignancies (1)
- Medicine (1)
- Mesocestoides corti (1)
- Mitochondria (1)
- Molekularpathologie (1)
- Monocytes and macrophages (1)
- Moose (1)
- Multiple myeloma (1)
- Multiple sclerosis (1)
- Mycobacterium tuberculosis (1)
- Myeloma (1)
- N-CAM (1)
- N-oleoyl serinol (1)
- NFATc1 (1)
- NFKB (1)
- NK cells (1)
- NRF2 (1)
- Nail unit (1)
- Neisseria meningitidis (1)
- Neuritis (1)
- NfL (1)
- Notch1 (1)
- Nucleus (1)
- PARM (1)
- PCI-32765 (1)
- PCLS (1)
- PKCζ, (1)
- PML (1)
- PO (1)
- Parkinsonism (1)
- Pathway (1)
- Placebo (1)
- Po (1)
- Polyadenylation (1)
- Polyadenylierung (1)
- Polymerase chain reaction (1)
- Polyoma-Virus (1)
- Prednisolon (1)
- Prodigy (1)
- Prognose (1)
- Proliferation (1)
- R0 (1)
- RNA (1)
- RNA export (1)
- RNA structure (1)
- RNS (1)
- RQQ domain (1)
- RSV-A ON1 (1)
- RT-qPCR (1)
- Ratte (1)
- Regulation of protease activity (1)
- Regulatory T cells (1)
- Regulatory-cells (1)
- RelB (1)
- Respiratory tract infection (1)
- Retroviren-Infektion (1)
- Rheumatoid arthritis (1)
- SARS-CoV-2 brain disorders (1)
- SARS‐CoV‐2 (1)
- SARS‐CoV‐2 infection (1)
- SLAM CDW150 (1)
- STEMI (1)
- STIM1 (1)
- STIM2 (1)
- Salmo trutta fario (1)
- Seahorse XF (1)
- Skint1 (1)
- Spumaviren (1)
- Superagonistic antibody (1)
- Suppression (1)
- T Cells (1)
- T cell (1)
- T cell activation (1)
- T cell acute lymphoblastic leukemia (1)
- T cell migration (1)
- T cell silencing (1)
- T cell suppression (1)
- T helper 1 cells (1)
- T helper cell responses (1)
- T-ALL (1)
- T-cell (1)
- TAB08 (1)
- TCF1 (1)
- TCF12 (1)
- TCR signaling cascade (1)
- TGN1412 (1)
- TLR2 (1)
- TLR4 (1)
- TNF (1)
- TRDV2 (1)
- TRGV9 (1)
- Tamoxifen (1)
- Tansania (1)
- Tanzania (1)
- Targeted Therapies (1)
- Th1 cells (1)
- Tiermodell (1)
- Tierversuch (1)
- Tr1 (1)
- Transcription (1)
- Tumor Microenvironment (1)
- Tumor-necrosis-factor (1)
- Uganda (1)
- VLA-1 (1)
- Vero E6 (1)
- Viral infections (1)
- Virology (1)
- Virus (1)
- Vγ9Vδ2 (1)
- Vγ9Vδ2 T cell (1)
- WASp (1)
- Waxy papulosis of childhood (1)
- Wiskott-Aldrich syndrome (1)
- Zentralnervensystem (1)
- acetylsalicylic acid (1)
- acid ceramidase (1)
- acquisition of host regulators (1)
- actins (1)
- activation (1)
- acute Graft versus Host Disease (1)
- acute graft-versus-host disease (1)
- acute heart failure (1)
- acute kidney injury (1)
- adaptive immune response (1)
- adenosine (1)
- adhesion (1)
- admission screening (1)
- adoptive transfer (1)
- adult (1)
- age groups (1)
- aging (1)
- allogeneic stem cell transplantation (1)
- alpha-globin (1)
- alternative splicing (1)
- alveoar echinococcosis (1)
- amplicon sequencing (1)
- anemia (1)
- anergy (1)
- angiogenesis (1)
- animal models (1)
- anthocyanin (1)
- anti-depressant drug (1)
- anti-hiv agents (1)
- anti-myocardial (1)
- anti-retroviral agents (1)
- antidepressants (1)
- antigen-B (1)
- antigenic recall (1)
- antimicrobial resistance (1)
- antiretrovirals (1)
- antiviral activity (1)
- antiviral treatment (1)
- antivirals (1)
- anti‐SARS‐CoV‐2‐spike IgG (1)
- anxiety (1)
- aorta (1)
- aorta ring (1)
- arthritis (1)
- aspirin (1)
- astaxanthin (1)
- attachment glycoprotein (1)
- autoantibodies (1)
- autoantibody (1)
- azapeptide nitriles (1)
- azido-ceramides (1)
- azidothymidine (1)
- bacteria (1)
- bacterial pathogens (1)
- bilberry (1)
- binding analysis (1)
- biochemical assays (1)
- bioinformatic (1)
- black currant (1)
- black trout syndrome (1)
- blocking opsonization (1)
- blocking phagocytosis (1)
- brain (1)
- brain bank (1)
- brain pathology (1)
- brain stem (1)
- branch point (1)
- brown trout (1)
- butyrophilin 2A1 (1)
- butyrophilins (1)
- cDC2 subset (1)
- calcium (1)
- calnexin (1)
- cancer microenvironment (1)
- canine distemper virus (1)
- cardiac magnetic resonance imaging (1)
- cardiorespiratory centre (1)
- caveolin-1 (Cav-1) (1)
- cell cycle and cell division (1)
- cell differentiation (1)
- cell line specificity pyridyl indole carboxylates (1)
- cell line-specificity (1)
- cell membrane (1)
- cell membrane model (1)
- cell migration (1)
- cell-cycle dependence (1)
- cells (1)
- cellular receptor (1)
- cellular stress responses (1)
- central-nervous-system (1)
- ceramidase (1)
- cerebrospinal fluid (1)
- channel (1)
- characterization and analytical techniques (1)
- child (1)
- children (1)
- cholera (1)
- cholesteryl ester (1)
- chondrogenesis (1)
- chromatin (1)
- chronic rhinosinusitis (1)
- circulation patterns (1)
- cis-acting sequences (1)
- co-evolution (1)
- co-stimulation, (1)
- coevolution (1)
- cognitive dysfunction (1)
- complement (1)
- complement factor H (1)
- complex (1)
- conversion (1)
- coronavirus (1)
- criteria (1)
- critically ill (1)
- cryptic peptides (1)
- cytokine release (1)
- cytokine responses (1)
- cytokines (1)
- cytoskeleton (1)
- decay (1)
- defective ribosomal products (1)
- degradation (1)
- demyelination (1)
- dengue virus (1)
- diacylglycerol (1)
- diet (1)
- differential diagnosis (1)
- differentiation (1)
- direct-acting antivirals (1)
- disease severity (1)
- dmrt1 (1)
- dna-binding protein (1)
- dogs (1)
- dopamine (1)
- drug adherence (1)
- drug discovery (1)
- drug interactions (1)
- embryo (1)
- encephalitis (1)
- endothelial cell infection (1)
- endothelial cells (1)
- enhance viral transcription (1)
- env leader protein (1)
- enzyme-linked immunoassays (1)
- enzymes (1)
- epicutaneous (1)
- epitope mapping (1)
- epitope specificity (1)
- epstein-barr virus (1)
- exclusion criteria (1)
- excretory-secretory (1)
- expression (1)
- factor H (1)
- fluorescence-activated cell sorting (1)
- fluoxetine (1)
- foamy retrovirus (1)
- foamyviruses (1)
- fungal infection (1)
- gamma-interferon (1)
- gammadelta T cells (1)
- gene delivery (1)
- gene-expression (1)
- genetic conservation (1)
- genetic interference (1)
- genetic variability (1)
- genetics (1)
- glial damage (1)
- glial fibrillary acidic protein (1)
- glycolipids (1)
- glycoproteins (1)
- glycosphingolipids (1)
- granulosus (1)
- group B genotype (1)
- group-A (1)
- guidelines (1)
- hACE2 (1)
- healthcare workers (1)
- heart (1)
- heart failure (1)
- helminth infection (1)
- helminths (1)
- hemagglutinin (1)
- hematological disorders (1)
- hepadnaviruses (1)
- heroine (1)
- herpes virus (1)
- highly-active antiretroviral therapy (1)
- histones (1)
- homeostasis (1)
- homing (1)
- host shutoff (1)
- host-pathogen interactions (1)
- human behaviour (1)
- human bocavirus (1)
- human cytomegalovirus (HCMV) (1)
- human immunodeficiency virus (1)
- human peripheral blood (1)
- humans (1)
- hydatid disease (1)
- immune activation (1)
- immune cells (1)
- immune control (1)
- immune escape (1)
- immune neuromelanin (1)
- immune response (1)
- immune suppression (1)
- immune therapy (1)
- immuno suppression (1)
- immunoglobulin superfamily (1)
- immunoprecipitation (1)
- immunosuppression (1)
- immunosurveillance (1)
- immunotherapy (1)
- improves survival (1)
- in vitro culture (1)
- in vivo (1)
- indinavir (1)
- inducible deletion (1)
- inducible nitric oxide synthase (1)
- infarction size (1)
- infected mice (1)
- infected-cell protein (1)
- infection control (1)
- infection spread (1)
- infectivity assays (1)
- influenza (1)
- influenza A virus (1)
- influenza virus (1)
- injecting drug users (1)
- innate immune response (1)
- innate lymphoid cells (1)
- interferon (1)
- interferon signaling (1)
- interferon γ (1)
- interleukin 1 receptor antagonist (1)
- interleukins (1)
- kidneys (1)
- large gene lists (1)
- larvae (1)
- lethality rate (1)
- leukemia (1)
- lipids (1)
- liposome (1)
- lithium (1)
- long terminal repeat (1)
- lymphocyte activation (1)
- lymphomas (1)
- lyso-phospholipids (1)
- mTORC1 (1)
- magnetic properties and materials (1)
- major depression (1)
- major histocompatibility complex (1)
- management (1)
- mediated suppression (1)
- medical (1)
- medical research (1)
- memory B cells (1)
- meningococcal disease (1)
- mesenchymal stem cell (1)
- messenger RNA (1)
- metacestode vesicles (1)
- mevalonate pathway (1)
- mice (1)
- microRNA (1)
- microbial mutation (1)
- microbiology (1)
- migration (1)
- molecular biology (1)
- molecular characterization (1)
- moonlighting (1)
- morbilliviruses (1)
- morphine (1)
- mortality (1)
- mothers (1)
- motif discovery (1)
- motifs (1)
- motility (1)
- mouse models (1)
- movement disorders (1)
- multi-drug resistance (1)
- multihit targeting (1)
- multiple myeloma (1)
- multiple sclerosis (1)
- murine cytomegalovirus (MCMV) (1)
- murine model (1)
- mutant mice (1)
- mutation databases (1)
- mycobacteria (1)
- myelin (1)
- myeloid-derived suppressor cell (MDSC) (1)
- myeloid-derived suppressor cells (MDSC) (1)
- myeloid-derived suppressor cells (MDSCs) (1)
- myocardial infarction (1)
- naloxone (1)
- nanoparticles (1)
- nasal polyps (1)
- necrosis-factor-alpha (1)
- nervous-system (1)
- neurodegeneration (1)
- neurofilament light chain (1)
- neuroinflammation (1)
- neuroinvasion (1)
- neurological symptoms/disorders (1)
- neurovirulence (1)
- neutral sphingomyelinase (1)
- neutral sphingomyelinase 2 (1)
- next generation sequencing (1)
- nine-banded armadillo (1)
- non-canonical translation (1)
- non-nucleoside reverse transcriptase inhibitors (1)
- nucleosides (1)
- oligomers (1)
- opioids (1)
- ortholog (1)
- orthoreovirus (1)
- outpatients (1)
- ovarian cancer (1)
- oxidative phosphorylation (1)
- oxidative stress (1)
- pH-regulated antigen 1 (Pra1) (1)
- parainfluenza virus (1)
- parasitic diseases (1)
- parasitology (1)
- pediatric infections (1)
- pediatrics (1)
- pellet culture (1)
- peptidomimetics (1)
- perspectives (1)
- phagocytosis (1)
- phosphoantigens (1)
- phospholipidosis (1)
- phylogenetic analysis (1)
- piscine orthoreovirus (1)
- placental mammals (1)
- plasminogen (1)
- pneumona virus (1)
- pol messenger-rna (1)
- polarization (1)
- poly(A) site usage (1)
- polyadenylation (1)
- polymicrobial sepsis (1)
- polymorphism (1)
- polyomavirus (1)
- polyomaviruses (1)
- population coverage (1)
- postmortem studies (1)
- pre-messenger RNA (1)
- precision-cut lung slices (1)
- prediction (1)
- prevention (1)
- primary cells (1)
- proliferative darkening syndrome (1)
- promoter-proximal pausing (1)
- protease inhibitors (1)
- protein sequencing (1)
- proteomic analysis (1)
- protocol (1)
- public health medicine (1)
- purine-rich element (1)
- quality of life (1)
- randomized controlled clinical trial (1)
- randomized controlled-trial (1)
- reactivation (1)
- recognition (1)
- recombinant proteins (1)
- recombination (1)
- regulatory T cells (Treg) (1)
- regulatory protein ICP27 (1)
- remdesivir (1)
- replication (1)
- respiratory syncytial virus (1)
- respiratory tract (1)
- retroviral infection (1)
- retroviral vectors (1)
- retroviruses (1)
- reverse transcriptase inhibitors (1)
- reverse transcriptase-polymerase chain reaction (1)
- reverse-transcriptase (1)
- reverse-transcriptase inhibitors (1)
- ribonuclease H (1)
- routine clinical-practice (1)
- salicylic acid (1)
- self-reactivity (1)
- sepsis (1)
- sequence (1)
- sequence databases (1)
- seroprevalence (1)
- serum (1)
- sex-determining gene (1)
- shock (1)
- sialic acid (1)
- signal transduction (1)
- simian foamy viruses (1)
- sphingolipid (1)
- sphingosine 1-phosphate (1)
- sphingosine kinase (1)
- spleen (1)
- splice regulation (1)
- splicing (1)
- splicing inhibition (1)
- spread (1)
- steady state (1)
- steady-state dendritic cells (1)
- sterol pathway (1)
- strains (1)
- stress (1)
- stroke (1)
- subacute sclerosing-panencephalitis (1)
- subgroup-B (1)
- subviral particle release (1)
- surface transport (1)
- surfactants (1)
- surveillance (1)
- tanzania (1)
- terminal gag domain (1)
- testing strategy (1)
- the microtubule-organizing center (1)
- therapy (1)
- thermal stresses (1)
- tissue (1)
- tolerance (1)
- tolerogenic dendritic cells (1)
- toll-like receptors (1)
- toxins (1)
- transcription factors (1)
- transcriptional profiling (1)
- transcriptional termination (1)
- transcriptomics (1)
- transcutaneous (1)
- transduction (1)
- transient regulatory T-cell targeting (1)
- transmembrane protein (1)
- tumor (1)
- tumor associated macrophages (1)
- tumour immunology (1)
- type 1 (1)
- type 1 ICP27 (1)
- tyrosine (1)
- ultraviolet radiation (1)
- unwindase (1)
- vaccination and immunization (1)
- vaccinia virus (1)
- vero cells (1)
- vesicles (1)
- viral epidemiology (1)
- viral microRNAs (1)
- viral pathology (1)
- viral replication (1)
- viral shedding (1)
- virus (1)
- virus budding (1)
- virus entry (1)
- virus host interaction (1)
- virus replication (1)
- virus vectors (1)
- virus-induced encephalitis (1)
- viruses (1)
- vitamin-D-receptor (1)
- vivo (1)
- wild-type (1)
- world health organization (1)
- α-synuclein-specific T cells (1)
- γδ T cells (1)
- γδ TCR (1)
Institut
- Institut für Virologie und Immunbiologie (221) (entfernen)
Sonstige beteiligte Institutionen
EU-Projektnummer / Contract (GA) number
- 721016 (2)
- 101041177 (1)
- 249177 (1)
- 825575 (1)
- 955974 (1)
- CoG 721016–HERPES (1)
- ERC-2016-CoG 721016-HERPES (1)
Aims
It has been hypothesized that cardiac decompensation accompanying acute heart failure (AHF) episodes generates a pro-inflammatory environment boosting an adaptive immune response against myocardial antigens, thus contributing to progression of heart failure (HF) and poor prognosis. We assessed the prevalence of anti-myocardial autoantibodies (AMyA) as biomarkers reflecting adaptive immune responses in patients admitted to the hospital for AHF, followed the change in AMyA titres for 6 months after discharge, and evaluated their prognostic utility.
Methods and results
AMyA were determined in n = 47 patients, median age 71 (quartiles 60; 80) years, 23 (49%) female, and 24 (51%) with HF with preserved ejection fraction, from blood collected at baseline (time point of hospitalization) and at 6 month follow-up (visit F6). Patients were followed for 18 months (visit F18). The prevalence of AMyA increased from baseline (n = 21, 45%) to F6 (n = 36, 77%; P < 0.001). At F6, the prevalence of AMyA was higher in patients with HF with preserved ejection fraction (n = 21, 88%) compared with patients with reduced ejection fraction (n = 14, 61%; P = 0.036). During the subsequent 12 months after F6, that is up to F18, patients with newly developed AMyA at F6 had a higher risk for the combined endpoint of death or rehospitalization for HF (hazard ratio 4.79, 95% confidence interval 1.13–20.21; P = 0.033) compared with patients with persistent or without AMyA at F6.
Conclusions
Our results support the hypothesis that AHF may induce patterns of adaptive immune responses. More studies in larger populations and well-defined patient subgroups are needed to further clarify the role of the adaptive immune system in HF progression.
Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
(2022)
Aspirin, with its active compound acetylsalicylic acid (ASA), shows antiviral activity against rhino- and influenza viruses at high concentrations. We sought to investigate whether ASA and its metabolite salicylic acid (SA) inhibit SARS-CoV-2 since it might use similar pathways to influenza viruses. The compound-treated cells were infected with SARS-CoV-2. Viral replication was analysed by RTqPCR. The compounds suppressed SARS-CoV-2 replication in cell culture cells and a patient-near replication system using human precision-cut lung slices by two orders of magnitude. While the compounds did not interfere with viral entry, it led to lower viral RNA expression after 24 h, indicating that post-entry pathways were inhibited by the compounds.
Background
Measles virus (MV) causes T cell suppression by interference with phosphatidylinositol-3-kinase (PI3K) activation. We previously found that this interference affected the activity of splice regulatory proteins and a T cell inhibitory protein isoform was produced from an alternatively spliced pre-mRNA.
Hypothesis
Differentially regulated and alternatively splice variant transcripts accumulating in response to PI3K abrogation in T cells potentially encode proteins involved in T cell silencing.
Methods
To test this hypothesis at the cellular level, we performed a Human Exon 1.0 ST Array on RNAs isolated from T cells stimulated only or stimulated after PI3K inhibition. We developed a simple algorithm based on a splicing index to detect genes that undergo alternative splicing (AS) or are differentially regulated (RG) upon T cell suppression.
Results
Applying our algorithm to the data, 9% of the genes were assigned as AS, while only 3% were attributed to RG. Though there are overlaps, AS and RG genes differed with regard to functional regulation, and were found to be enriched in different functional groups. AS genes targeted extracellular matrix (ECM)-receptor interaction and focal adhesion pathways, while RG genes were mainly enriched in cytokine-receptor interaction and Jak-STAT. When combined, AS/RG dependent alterations targeted pathways essential for T cell receptor signaling, cytoskeletal dynamics and cell cycle entry.
Conclusions
PI3K abrogation interferes with key T cell activation processes through both differential expression and alternative splicing, which together actively contribute to T cell suppression.
A Review of the Multipronged Attack of Herpes Simplex Virus 1 on the Host Transcriptional Machinery
(2021)
During lytic infection, herpes simplex virus (HSV) 1 induces a rapid shutoff of host RNA synthesis while redirecting transcriptional machinery to viral genes. In addition to being a major human pathogen, there is burgeoning clinical interest in HSV as a vector in gene delivery and oncolytic therapies, necessitating research into transcriptional control. This review summarizes the array of impacts that HSV has on RNA Polymerase (Pol) II, which transcribes all mRNA in infected cells. We discuss alterations in Pol II holoenzymes, post-translational modifications, and how viral proteins regulate specific activities such as promoter-proximal pausing, splicing, histone repositioning, and termination with respect to host genes. Recent technological innovations that have reshaped our understanding of previous observations are summarized in detail, along with specific research directions and technical considerations for future studies.
Background:
The foamy viral genome encodes four central purine-rich elements localized in the integrase-coding region of pol. Previously, we have shown that the first two of these RNA elements (A and B) are required for protease dimerization and activation. The D element functions as internal polypurine tract during reverse transcription. Peters et al., described the third element (C) as essential for gag expression suggesting that it might serve as an RNA export element for the unspliced genomic transcript.
Results:
Here, we analysed env splicing and demonstrate that the described C element composed of three GAA repeats known to bind SR proteins regulates env splicing, thus balancing the amount of gag/pol mRNAs. Deletion of the C element effectively promotes a splice site switch from a newly identified env splice acceptor to the intrinsically strong downstream localised env 3′ splice acceptor permitting complete splicing of almost all LTR derived transcripts. We provide evidence that repression of this env splice acceptor is a prerequisite for gag expression. This repression is achieved by the C element, resulting in impaired branch point recognition and SF1/mBBP binding. Separating the branch point from the overlapping purine-rich C element, by insertion of only 20 nucleotides, liberated repression and fully restored splicing to the intrinsically strong env 3′ splice site. This indicated that the cis-acting element might repress splicing by blocking the recognition of essential splice site signals.
Conclusions:
The foamy viral purine-rich C element regulates splicing by suppressing the branch point recognition of the strongest env splice acceptor. It is essential for the formation of unspliced gag and singly spliced pol transcripts.
Background: Hypnales comprise over 50% of all pleurocarpous mosses. They provide a young radiation complicating phylogenetic analyses. To resolve the hypnalean phylogeny, it is necessary to use a phylogenetic marker providing highly variable features to resolve species on the one hand and conserved features enabling a backbone analysis on the other. Therefore we used highly variable internal transcribed spacer 2 (ITS2) sequences and conserved secondary structures, as deposited with the ITS2 Database, simultaneously. Findings: We built an accurate and in parts robustly resolved large scale phylogeny for 1,634 currently available hypnalean ITS2 sequence-structure pairs. Conclusions: Profile Neighbor-Joining revealed a possible hypnalean backbone, indicating that most of the hypnalean taxa classified as different moss families are polyphyletic assemblages awaiting taxonomic changes.
Both, jawless and jawed vertebrates possess three lymphocyte lineages defined by highly diverse antigen receptors: Two T‐cell‐ and one B‐cell‐like lineage. In both phylogenetic groups, the theoretically possible number of individual antigen receptor specificities can even outnumber that of lymphocytes of a whole organism. Despite fundamental differences in structure and genetics of these antigen receptors, convergent evolution led to functional similarities between the lineages. Jawed vertebrates possess αβ and γδ T‐cells defined by eponymous αβ and γδ T‐cell antigen receptors (TCRs). “Conventional” αβ T‐cells recognize complexes of Major Histocompatibility Complex (MHC) class I and II molecules and peptides. Non‐conventional T‐cells, which can be αβ or γδ T‐cells, recognize a large variety of ligands and differ strongly in phenotype and function between species and within an organism. This review describes similarities and differences of non‐conventional T‐cells of various species and discusses ligands and functions of their TCRs. A special focus is laid on Vγ9Vδ2 T‐cells whose TCRs act as sensors for phosphorylated isoprenoid metabolites, so‐called phosphoantigens (PAg), associated with microbial infections or altered host metabolism in cancer or after drug treatment. We discuss the role of butyrophilin (BTN)3A and BTN2A1 in PAg‐sensing and how species comparison can help in a better understanding of this human Vγ9Vδ2 T‐cell subset.
Butyrophilin (BTN)–3A and BTN2A1 molecules control the activation of human Vγ9Vδ2 T cells during T cell receptor (TCR)-mediated sensing of phosphoantigens (PAg) derived from microbes and tumors. However, the molecular rules governing PAg sensing remain largely unknown. Here, we establish three mechanistic principles of PAg-mediated γδ T cell activation. First, in humans, following PAg binding to the intracellular BTN3A1-B30.2 domain, Vγ9Vδ2 TCR triggering involves the extracellular V-domain of BTN3A2/BTN3A3. Moreover, the localization of both protein domains on different chains of the BTN3A homo-or heteromers is essential for efficient PAg-mediated activation. Second, the formation of BTN3A homo-or heteromers, which differ in intracellular trafficking and conformation, is controlled by molecular interactions between the juxtamembrane regions of the BTN3A chains. Finally, the ability of PAg not simply to bind BTN3A-B30.2, but to promote its subsequent interaction with the BTN2A1-B30.2 domain, is essential for T-cell activation. Defining these determinants of cooperation and the division of labor in BTN proteins improves our understanding of PAg sensing and elucidates a mode of action that may apply to other BTN family members.
Background
Anthocyanin-containing plant extracts and carotenoids, such as astaxanthin, have been well-known for their antiviral and anti-inflammatory activity, respectively. We hypothesised that a mixture of Ribes nigrum L. (Grossulariaceae) (common name black currant (BC)) and Vaccinium myrtillus L. (Ericaceae) (common name bilberry (BL)) extracts (BC/BL) with standardised anthocyanin content as well as single plant extracts interfered with the replication of Measles virus and Herpesviruses in vitro.
Methods
We treated cell cultures with BC/BL or defined single plant extracts, purified anthocyanins and astaxanthin in different concentrations and subsequently infected the cultures with the Measles virus (wild-type or vaccine strain Edmonston), Herpesvirus 1 or 8, or murine Cytomegalovirus. Then, we analysed the number of infected cells and viral infectivity and compared the data to non-treated controls.
Results
The BC/BL extract inhibited wild-type Measles virus replication, syncytia formation and cell-to-cell spread. This suppression was dependent on the wild-type virus-receptor-interaction since the Measles vaccine strain was unaffected by BC/BL treatment. Furthermore, the evidence was provided that the delphinidin-3-rutinoside chloride, a component of BC/BL, and purified astaxanthin, were effective anti-Measles virus compounds. Human Herpesvirus 1 and murine Cytomegalovirus replication was inhibited by BC/BL, single bilberry or black currant extracts, and the BC/BL component delphinidin-3-glucoside chloride. Additionally, we observed that BC/BL seemed to act synergistically with aciclovir. Moreover, BC/BL, the single bilberry and black currant extracts, and the BC/BL components delphinidin-3-glucoside chloride, cyanidin-3-glucoside, delphinidin-3-rutinoside chloride, and petunidin-3-galactoside inhibited human Herpesvirus 8 replication.
Conclusions
Our data indicate that Measles viruses and Herpesviruses are differentially susceptible to a specific BC/BL mixture, single plant extracts, purified anthocyanins and astaxanthin. These compounds might be used in the prevention of viral diseases and in addition to direct-acting antivirals, such as aciclovir.
The role of regulatory T cells (Tregs) in bacterial sepsis remains controversial because antibody-mediated depletion experiments gave conflicting results. We employed DEREG mice (DEpletion of REGulatory T cells) and a caecal ligation and puncture model to elucidate the role of \(CD4^+Foxp3^+\) Tregs in sepsis. In DEREG mice natural Tregs can be visualized easily and selectively depleted by diphtheria toxin because the animals express the diphtheria toxin receptor and enhanced green fluorescent protein as a fusion protein under the control of the foxp3 locus. We confirmed rapid Treg-activation and an increased ratio of Tregs to Teffs in sepsis. Nevertheless, 24 h after sepsis induction, Treg-depleted and control mice showed equally strong inflammation, immune cell immigration into the peritoneum and bacterial dissemination. During the first 36 h of disease survival was not influenced by Treg-depletion. Later, however, only Treg-competent animals recovered from the insult. We conclude that the suppressive capacity of Tregs is not sufficient to control overwhelming inflammation and early mortality, but is a prerequisite for the recovery from severe sepsis.